Violet sodium polysulfide aluminosilicate with a SOD-type framework structure

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (non-LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From 3rd August 1981 to 25th August 1981

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study with acceptable restrictions

Remarks:

Test method is similar to OECD guideline 406. No GLP study.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1981

Report date:

1981

Materials and methods

Test guideline

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 406 (Skin Sensitisation)

Deviations:

no

GLP compliance:

no

Type of study:

guinea pig maximisation test

Justification for non-LLNA method:

No information available

Test material

Test material information

Constituent 1

Reference substance name:

Sodium polysulfide aluminosilicate with a SOD-type framework structure

EC Number:

701-340-9

Molecular formula:

|Na+6-x+y+z (S2•-)y(S3•-)z|[Al6-x Si6+x O24] - SOD Where: 6 ≤ 6-x+y+z ≤ 8 0 ≤ x ≤ 1.2 1 ≤ y+z ≤ 2

IUPAC Name:

Sodium polysulfide aluminosilicate with a SOD-type framework structure

Test material form:

solid: particulate/powder

Details on test material:

- Physical state: a blue powder

Specific details on test material used for the study:

Lot/batch nº: 1

In vivo test system

Test animals

Species:

guinea pig

Strain:

Dunkin-Hartley

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS- Source: D.Hall, Darley Oaks, Burton-on-trent, Staffordshire- Age at study initiation: young- Weight at study initiation: 300-500g- Housing: in groups up to a maximum of five in a thermostatically controlled room- Diet (e.g. ad libitum): TR2 with added vitamin C, ad libitum- Water (e.g. ad libitum): tap water containing 0.01% vitamin C, ad libitumENVIRONMENTAL CONDITIONS- Temperature (°C): 18 ± 3ºC- Photoperiod (hrs dark / hrs light): 14 hours light/10 hours dark per day in every 24 hour cycle

Study design: in vivo (non-LLNA)

Induction

Induction 1

Route:

intradermal and epicutaneous

Vehicle:

water

Concentration / amount:

Injection: 1.- Without Complete Freund´s Adjuvant: 0.5 g of the test material suspended in 7.5 ml of sterile distilled water (6.25%). This was the maximum concentration that could be injected.2.- With Complete Freund´s Adjuvant: 5 ml of a 12.5% aqueous suspension of the test material emulsified with 5 ml of Complete Freund´s Adjuvant.

Induction 2

Route:

intradermal and epicutaneous

Vehicle:

water

Concentration / amount:

Topical application: a 50% concentration in sterile distilled water

Challenge

No.:

#1

Route:

epicutaneous, occlusive

Vehicle:

water

Concentration / amount:

25% and 12.5% concentration in sterile distilled water

No. of animals per dose:

20

Details on study design:

RANGE FINDING TESTS:Before the start of the challenge stage of the study the likely maximum non-irritant concentration of the test substance was determined by a range-finding study in a separate group of animals. Four guinea pigs which had been pretreated with Complete Freund´s Adjuvant were used. An 8 x 5 cm area of skin of both flanks of the selected animals was closely clipped. Four concentrations of the test substance in the chosen vehicle were prepared. Concentrations were 100%, 50%, 25% and 12.5% of the supplied test material. Four patches of 2 x 2 cm Whatman No. 3 filter paper each saturated with a different concentration of the test substance preparation were applied to each animal, two patches to each flank. The patches were covered occlusively and secured by two adhesive bandages in the same way as the induction topical application patch assemblies. The patches were removed after 24 hours. The application sites were examined for signs of redness and swelling 24 and 48 hours after the removal of the patches. MAIN STUDYA. INDUCTION EXPOSUREIntradermal injection: Three pairs of injections were made on either side of the centre of an areea 4 x 6 cm clipped over the shoulder of the animal. A row of three injections was made on each side: 1.- 0.1 ml Complete Freund´s Adjuvant 2.- 0.1 ml of test substance alone3.- 0.05 ml of test substance emulsified with 0.05 ml of Complete Freund´s Adjuvant.Topical application: one week after injection the same area was closely clipped. A 4 x 2 cm patch of Whatman No. 3 filter paper was saturated with the prepared test substance and applied to the skin of the clipped area. The patch was secured by an overlapping impermeable plastic 5 cm Blenderm adhesive tape. This was secured by elastic bandage wound around the torso of the animal and left in position for 48 hours. B. CHALLENGE EXPOSUREThe animals were challenged 2 weeks after the topical induction application. The prepared test substance was applied to a 2 x 2 cm piece of filter paper. The patch was applied and secured for 24 h. - Evaluation (hr after challenge): 24 h after removal of the patch and 48 h after removal of the patch

Challenge controls:

Challenge control phase: 20 additional guinea pigs were treated in a similar manner to the test animals except that the test sample was only applied at the challenge phase

Positive control substance(s):

no

Results and discussion

In vivo (non-LLNA)

Results

Results 1

Key result

Reading:

1st reading

Hours after challenge:

24

Group:

test chemical

Dose level:

25% and 12.5% concentration of the test material

No. with + reactions:

0

Total no. in group:

20

Clinical observations:

No visible reactions

Results 2

Reading:

1st reading

Group:

negative control

Remarks on result:

not measured/tested

Results 3

Reading:

1st reading

Group:

positive control

Remarks on result:

not measured/tested

Any other information on results incl. tables

No visible reaction was exhibited by any animal in the test or control group when challenged with 25% and 12.5% concentrations of hte test material in sterile distilled water.

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Remarks:

not sensitising

Conclusions:

There was no evidence suggesting that the test material acts as a sensitiser in the guinea pig. It would be classified as non-allergenic or as a week (Grade I) sensitiser on the Magnusson and Kligman scale, having a sensitisation rate of 0-8%.

Executive summary:

The aim of this study was to determine the skin sensitisation potential of the test material using the guinea pig maximisation test. The procedure used is that described by B.Magnusson and A.M. Kligman (J. Invt. Derm. 1969 52pp.268 -276) (similar to OECD Guideline 406). Twenty guinea pigs were treated by intradermal injection in the shoulder region in an attempt to induce sensitisation (injection induction phase). 7 days later the potential sensitisation process was boosted by an application of the test material over the injection site (topical application induction phase). The animals were challenged 14 days later by application of the test material to the flank for 24 hours with a 25% and 12.5% concentration of the test material. There was no evidence suggesting that the test material acts as a sensitiser in the guinea pig. It would be classified as non-allergenic or as a week (Grade I) sensitiser on the Magnusson and Kligman scale, having a sensitisation rate of 0-8%.